PEER-REVIEWED PUBLICATIONS
Breadcrumb
Clinical Futures investigators are international experts in their clinical research related fields and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here, you can access Clinical Futures journal article abstracts by author, title, or year.
2026
Safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir-rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multinational, phase 1/2, single-arm study
The lancet. HIV, 2026
Aditya Gaur, Kristin Baltrusaitis, Edmund Capparelli V, John Moye, Dwight Yin, Gaerolwe Masheto, Sarah Buisson, Conn Harrington, Mark Marzinke, Elizabeth Lowenthal, Rachel Scheckter, Andi Ace, Shawn Ward, Ryan Milligan, Kyle Whitson, Jenny Huang, S Cheung, Brookie Best, Ellen Townley, Gilly Roberts, Thomas Kakuda, Eileen Birmingham, Sisinyana Mathiba, Linda Aurpibul, Violet Korutaro, Christiana Smith, Faeezah Patel, Evette Moodley, Carolyn Bolton-Moore, IMPAACT Collaborators, IMPAACT Team
The lancet. HIV, 2026
Aditya Gaur, Kristin Baltrusaitis, Edmund Capparelli V, John Moye, Dwight Yin, Gaerolwe Masheto, Sarah Buisson, Conn Harrington, Mark Marzinke, Elizabeth Lowenthal, Rachel Scheckter, Andi Ace, Shawn Ward, Ryan Milligan, Kyle Whitson, Jenny Huang, S Cheung, Brookie Best, Ellen Townley, Gilly Roberts, Thomas Kakuda, Eileen Birmingham, Sisinyana Mathiba, Linda Aurpibul, Violet Korutaro, Christiana Smith, Faeezah Patel, Evette Moodley, Carolyn Bolton-Moore, IMPAACT Collaborators, IMPAACT Team
Acceptability and tolerability of long-acting injectable cabotegravir-rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial
The lancet. HIV, 2026
Elizabeth Lowenthal, Jennifer Chapman, Kristin Baltrusaitis, Grace Kovic, Sanjna Merchant, Kaleb Branch, Chermiqua Tsosie, Martina Vaca, Barbara Heckman, Rodica Van Solingen-Ristea, Conn Harrington, Dwight Yin, Ellen Townley, Michael Whitton, Allison Agwu, Christiana Smith, Mary Paul, Avy Violari, Evette Moodley, Maxensia Owor, Kulkanya Chokephaibulkit, Samantha Fry, Jennifer Jao, Charles Mitchell, Sarah Buisson, Andi Ace, Irina Kolobova, Carolyn Bolton-Moore, Aditya Gaur, IMPAACT Collaborators, IMPAACT Team
The lancet. HIV, 2026
Elizabeth Lowenthal, Jennifer Chapman, Kristin Baltrusaitis, Grace Kovic, Sanjna Merchant, Kaleb Branch, Chermiqua Tsosie, Martina Vaca, Barbara Heckman, Rodica Van Solingen-Ristea, Conn Harrington, Dwight Yin, Ellen Townley, Michael Whitton, Allison Agwu, Christiana Smith, Mary Paul, Avy Violari, Evette Moodley, Maxensia Owor, Kulkanya Chokephaibulkit, Samantha Fry, Jennifer Jao, Charles Mitchell, Sarah Buisson, Andi Ace, Irina Kolobova, Carolyn Bolton-Moore, Aditya Gaur, IMPAACT Collaborators, IMPAACT Team
2025
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
The lancet. HIV, 2025
Carolyn Moore, Kristin Baltrusaitis, Brookie Best, John Moye, Ellen Townley, Avy Violari, Barbara Heckman, Sarah Buisson, Rodica Van Solingen-Ristea, Edmund Capparelli V, Mark Marzinke, Elizabeth Lowenthal, Shawn Ward, Chelsea Krotje, Ryan Milligan, Allison Agwu, Jenny Huang, S Cheung, Cynthia McCoig, Dwight Yin, Gilly Roberts, Herta Crauwels, Veerle Van Eygen, Sara Zabih, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Violet Korutaro, Aditya Gaur, IMPAACT Team
The lancet. HIV, 2025
Carolyn Moore, Kristin Baltrusaitis, Brookie Best, John Moye, Ellen Townley, Avy Violari, Barbara Heckman, Sarah Buisson, Rodica Van Solingen-Ristea, Edmund Capparelli V, Mark Marzinke, Elizabeth Lowenthal, Shawn Ward, Chelsea Krotje, Ryan Milligan, Allison Agwu, Jenny Huang, S Cheung, Cynthia McCoig, Dwight Yin, Gilly Roberts, Herta Crauwels, Veerle Van Eygen, Sara Zabih, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Violet Korutaro, Aditya Gaur, IMPAACT Team


